HDAC inhibitors and Alzheimer's; New gene for breast cancer; Genetic variants may help guide rheumatoid arthritis therapy;

> Studying HDAC inhibitors in Alzheimer's, investigators at Scripps "found evidence that better synapse growth was associated with less specific inhibition of Class 1 HDACs. There was a clear correlation between synapse building-- which may lead to improved network power--and memory restoration by the different HDAC inhibitors." Release

> A study led by Women's College Hospital researcher Dr. Mohammad Akbari has identified a new breast cancer gene. Release

> Scientists at The University of Manchester have pointed to specific genetic variants that may eventually be used to guide treatment of rheumatoid arthritis. Release

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.